Результаты поиска

Опыт, накопленный пациентами в ходе видеоконференций: качественный систематический обзор.

Консультация Video (VC) приобрела жизненно важное значение для улучшения доступа к медицинскому обслуживанию во время пандемии COVID-19 и остается таковой. Несмотря на доказательства эффективности, проблемы, включая технологическую грамотность и несоответствия в опыте, указывают на необходимость проведения более широких исследований, ориентированных на пациентов. Несмотря на то, что пациенты ценят удобство ВК, проблемы, возникающие во время сложных проблем и предпочтения пациентов в плане личного ухода, сохраняются. Обобщение качественных исследований дает представление о фрагментированном пон

A Multi-step Approach to Adapting a Mind-Body Resiliency Intervention for Fear of Cancer Recurrence and Uncertainty in Survivorship (IN FOCUS).

BackgroundFor cancer survivors, there is a paucity of fear of recurrence (FOR) interventions that integrate empirically supported mind-body and psychological skills for managing FOR and are delivered in scalable formats.ObjectiveTo adapt an evidence-based resiliency intervention to address FOR among cancer survivors.MethodsA multidisciplinary team of researchers, clinicians, and patient stakeholders followed an iterative intervention adaptation process (ORBIT). In Step 1, we sought to define key FOR management skills through a literature review and feedback from stakeholders. In Step 2, we int

Expert consensus on resection of chest wall tumors and chest wall reconstruction.

Chest wall tumors are a relatively uncommon disease in clinical practice. Most of the published studies about chest wall tumors are usually single-center retrospective studies, involving few patients. Therefore, evidences regarding clinical conclusions about chest wall tumors are lacking, and some controversial issues have still to be agreed upon. In January 2019, 73 experts in thoracic surgery, plastic surgery, science, and engineering jointly released the Chinese Expert Consensus on Chest Wall Tumor Resection and Chest Wall Reconstruction (2018 edition). After that, numerous experts put forw

New Drug Approvals in China: An International Comparative Analysis, 2019-2023.

PurposeOver the past five years, China's pharmaceutical industry has rapidly developed but still lags behind global leaders. This study aims to analyze and compare the trends in new drug approvals in China, the United States (US), the European Union (EU), and Japan from 2019 to 2023.MethodsData on new drug approvals were collected from the National Medical Products Administration (NMPA), Food and Drug Administration (FDA), European Medicines Agency (EMA), and Pharmaceuticals and Medical Devices Agency (PMDA), including information on the generic name, trade name, applicants, target, approval d

Риск синхронных и вторых первичных недугов у поддающихся трансплантации пациентов с множественным миэломой, обработанных линалидомидом.

Согласно сообщениям, повышенный риск возникновения вторых первичных магнентов (СМП) для лиц, имеющих право на трансплантацию (ТИ), с недавно поставленным диагнозом множественной миеломы (НДММ), подвергающихся воздействию линалидомида (Лен), при том понимании, что Лен часто соприкасался с алкилирующими агентами и что исследования не исключали синхронных маньянов (СИМ). Мы поставили перед собой цель оценить соответствующий СИМ в отношении рисков, связанных с СМП у пациентов ТИ, которые лечили с Леном как прифронтовой терапией. Мы провели исследование на основе регистрации раковых заболеваний с в

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk.

A cohort of 650 patients treated for localized prostate cancer (PCa) with CyberKnifeTM ultra-hypofractionated radiotherapy between 2011 and 2018 was retrospectively analyzed in terms of survival, patterns of failure, and outcomes of second-line definitive salvage therapies. The analysis was performed using survival analysis including the Kaplan-Meier method and Cox regression analysis. At a median follow-up of 49.4 months, the main pattern of failure was local-regional failure (7.4% in low-, and 13% in intermediate/high-risk group at five years), followed by distant metastases (3.6% in low-, a

Совпадение в полном тексте источника
… Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer N. Engl. J. Med. 2014 370 932 942 10.1056/NEJMoa1311593 24597866 PMC4118145 7. Litwin M.S. Tan H.J. The Diagnosis and Treatment of Prostate Cancer: A Review JAMA 2017 317 2532 2542 10.1001/jama.2017.7248 28655021 8. Palma D.A. …

Calculated globulin (CG) as a screening test for antibody deficiency.

Calculated globulin (total protein - albumin) is usually tested as part of a liver function test profile in both primary and secondary care and determines the serum globulin concentration, of which immunoglobulins are a major component. The main use hitherto of calculated globulin is to detect paraproteins when the level is high. This study investigated the potential to use low levels of calculated globulin to detect antibody deficiency. Serum samples with calculated globulin cut-off < 18 g/l based on results of a pilot study were collected from nine hospitals in Wales over a 12-month period.

Совпадение в полном тексте источника
… As part of the process of test profile harmonization and demand management 23 it has been suggested that ‘its inclusion is more as an opportunistic screening test for monoclonal gammopathy, but no specific intervention exists other than watchful waiting’ 24 . …

Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy.

ObjectiveTo map the journey and needs of patients receiving chimeric antigen receptor T-cell (CAR-T) therapy, providing a reference for improving the comprehensive management of patients receiving clinical CAR-T cell therapy, as well as enhancing patients' overall well-being.MethodsA qualitative grounded theory approach was used. From August 2024 to January 2025, patients receiving CAR-T cell therapy at a university hospital in Wuhan, China, were enrolled through purposive sampling. The research data were collected from descriptive observation, focused observation, and selective observation. T

The Survivor Unmet Needs Survey (SUNS) for haematological cancer survivors: a cross-sectional study assessing the relevance and psychometric properties.

BackgroundRelevant and psychometrically sound needs assessment tools are necessary for accurate assessment of haematological cancer survivors unmet needs. No previous study has developed nor psychometrically evaluated a comprehensive needs assessment tool for use with population-based samples of haematological cancer survivors. This study aimed to assess the validity and reliability of the Survivor Unmet Needs Survey (SUNS) with haematological cancer survivors.MethodsThe relevance, content and face validity of the SUNS to haematological cancer survivors was assessed using qualitative interview

Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party.

Pure red cell aplasia (PRCA) is a relevant complication after ABO-mismatched allogeneic hematopoietic cell transplantation (HCT). No standard treatment exists, and practice is heterogenous. In this study, we took advantage of an international collaboration to describe characteristics and outcomes of patients receiving daratumumab for PRCA following first allogeneic HCT. We identified 45 patients meeting these criteria (median patient age, 56 years). The median time from HCT to PRCA was 55 days (IQR, 36-116) and all patients were transfusion-dependent at time of daratumumab start. Daratumumab w

Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients.

IntroductionThe incidence of most cancers increases with age and cancer is a leading cause of morbidity and mortality in the older population. Older cancer patients frequently have additional co-morbidities and functional decline, which can substantially affect treatment outcomes. Major oncology societies recommend a screening for geriatric impairments in patients at risk (e.g. G8), followed by a comprehensive geriatric assessment (CGA). Nevertheless, CGA is often not established in routine care. We describe the implementation process of CGA in patients with hematological cancers at the Univer

Neutropenic sepsis and septic shock in ICU patients: A single-center experience over the last decade.

PURPOSE: Sepsis and septic shock in patients with neutropenia are associated with high mortality. We investigated the features and outcome predictors of neutropenic sepsis in the last decade. METHODS: Consecutive patients who were admitted to the intensive care unit (ICU) of a French university-affiliated hospital in 2012-2022, met criteria for sepsis or septic shock, and had neutropenia were included retrospectively. Patient features were collected and compared for 2012-2017 and 2018-2022. Factors associated with hospital mortality were sought by univariate and multivariate analyses. RESULT

Совпадение в полном тексте источника
… Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med. 2004;30(6):1073–80. doi: 10.1007/s00134-004-2212-x 37. Lorente L, Martín MM, Vidal P, Rebollo S, Ostabal MI, Solé-Violán J, et al. …

Qualitative study of kinesiophobia in patients with tumors after PICC catheterization.

To explore the kinesiophobia experience of patients with tumors after PICC catheterization and to analyze patients' views and true inner feelings about kinesiophobia, with the goal of providing a reference for reducing the occurrence of kinesiophobia and enhancing the experience of patients undergoing this procedure. A purposive sampling method was used to select patients with tumors that required the placement of a PICC line in a tertiary hospital in Ningbo City, Zhejiang Province, as the research object. A semistructured in-depth interview method was used for data collection, and the content

Характеристики реального мира и результаты лечения пациентов с повышенным и не связанным с повышенным риском множественным миелом с использованием базы данных Flatiron Health.

Цель этого исследования состояла в том, чтобы представить реальные данные о риске развития у пациентов с множественным миэломой (ШМ) повышенного риска. Это ретроспективное исследование позволило получить данные из базы данных Flatiron Health. Пациенты, имеющие на это право, имели ШМ и соответствующие меры по применению принципа майо 2018Международная рабочая группа по миеломе (МРГ) 2020, и критерии экспериментального риска AQUILA. Время перехода к активной MM (TTP), прогрессии или смерти (PFS) и смерти или прогрессии на первой линии MM-терапии (PFS2) оценивалось с использованием методов Kapan-

Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study.

Our aim was to assess the detection rate (DR) of positron emission computed tomography (PET/CT) with anti-1-amino-3-[18F]-flurocyclobutane-1-carboxylic acid (18F-FACBC) in patients with biochemical recurrence (BCR) from prostate cancer (PC). As a secondary endpoint, we evaluated 18F-FACBC PET/CT's impact on patients management. Clinical records of 81 patients submitted to 18F-FACBC PET/CT due to PC BCR in two Italian Nuclear Medicine Units were retrospectively assessed. DR was gauged in the whole cohort and stratifying patients by discrete intervals of PSA levels. PET/CT's impact on clinical m

Совпадение в полном тексте источника
… Furthermore, the authors registered a meaningful impact of PET/CT on patients’ clinical management, with the major changes being the switch from an intended systemic/salvage therapy to watchful waiting (24%) and from salvage therapy to systemic therapy (24%). …

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.

Mutation in the CTNNB1 gene, leading to a deregulation of the WTN/β-catenin pathway, is a common feature of desmoid tumors (DTs). Many β-catenin inhibitors have recently been tested in clinical studies; however, BC2059 (also referred as Tegavivint), a selective inhibitor of nuclear β-catenin that works through binding TBL-1, is the only one being evaluated in a clinical study, specifically for treatment of desmoid tumor patients. Preclinical studies on BC2059 have shown activity in multiple myeloma, acute myeloid leukemia and osteosarcoma. Our preclinical studies provide data on the efficacy o

Совпадение в полном тексте источника
… A “watchful waiting” approach has been implemented in some centers if the lesion is not causing functional difficulty [ 10 ]; however, due to the unpredictable natural history and clinical behavior of this disease, there is controversy in crafting a universal treatment strategy for DT patients [ 11 ] …

Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.

Syndecan-1 (CD138) is a transmembrane proteoglycan expressed in various normal and malignant tissues. It is of interest due to a possible prognostic effect in tumors and its role as a target for the antibody-drug conjugate indatuximab ravtansine. Here, we analyzed 17,747 prostate cancers by immunohistochemistry. Membranous and cytoplasmic CD138 staining was separately recorded. In normal prostate glands, CD138 staining was limited to basal cells. In cancers, membranous CD138 positivity was seen in 19.6% and cytoplasmic CD138 staining in 11.2% of 12,851 interpretable cases. A comparison with cl

Совпадение в полном тексте источника
… Radical prostatectomy versus watchful waiting in early prostate cancer The New England Journal of Medicine 2011 364 18 1708 1717 10.1056/NEJMoa1011967 2-s2.0-79955705831 21542742 3 Wilt T. J. Jones K. M. Barry M. J. …

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.

Among monoclonal gammopathies of undetermined significance (MGUSs), the immunoglobulin M (IgM) MGUS subtype stands as a unique entity and plays a pivotal role as a pre-malignant condition for multiple B-cell non-Hodgkin lymphomas, most notably Waldenström macroglobulinemia (WM). A relationship between IgM MGUS and WM has been proposed for decades. However, insight regarding the pathobiology of these two conditions improved significantly in recent years, strengthening the hypothesis that WM and IgM MGUS are different stages of the same disease. Therefore, the understanding of IgM MGUS and that

Latent profile analysis of fear of progression in Chinese hematologic malignancy survivors.

Fear of disease progression (FoP) is a multidimensional concept that refers to the fear or worry about disease progress. Little is known about the distinct FoP profiles and their determinants in culturally specific contexts, especially among hematologic malignancies (HM) patients in China. This study aimed to identify heterogeneous profiles of FoP and their associated predictors among Chinese patients with HM. A convenience sample of patients suffering from HM were enrolled from March 2023 to February 2024. To gather multidimensional data from the Fear of Progression Questionnaire-Short Form (

Совпадение в полном тексте источника
… Therefore, the characteristic relapse-remitting course of lymphoma may impose a unique psychological burden 63 , as patients must continuously face the uncertainty of the “watchful waiting” period and the cumulative pressure of multi-line treatments. …

Prehabilitation Exercise Training to Target Improved Muscle Strength in Pretransplant Patients Diagnosed With Multiple Myeloma: Protocol for a Pilot Randomized Controlled Trial.

BACKGROUND: Muscle mass and strength are severely compromised in patients diagnosed with multiple myeloma, such that the risk of poor overall survival increases as the prevalence of low muscle mass, also known as sarcopenia, increases. Additionally, at the time of autologous stem cell transplant (ASCT), 51% of patients experience low muscle mass and strength, which can prolong hospitalization and lead to increased risk of obesity, insulin resistance, lowered physical function, and poor quality of life. OBJECTIVE: The PROTECT (Prehabilitation Exercise Training in Multiple Myeloma Patients Unde